Next report date
Report period
H2 2024
EPS estimate
—
Revenue estimate
—
−13.87 MUSD
2.26 MUSD
44.22 M
Om ARGENT BIOPHARMA LIMITED
Sektor
Bransch
VD
Roby Reuven Zomer
Webbplats
Huvudkvarter
Perth
Grundat
2005
ISIN
AU0000326647
FIGI
BBG00G02RF51
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
